AJHP Voices: Recent and anticipated novel drug approvals for 2023 and 2024

In this podcast, Dr. Matthew Rim and Dr. Andrew Levitsky discuss the AJHP Special Feature, “Recent and anticipated novel drug approvals for 2023 and 2024,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.